Search results
AbbVie Inc. (NYSE:ABBV) Shares Bought by Bell Investment Advisors Inc
ETF DAILY NEWS· 24 hours ago(NYSE:ABBV – Free Report) by 6.6% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,031 shares of the company’s stock& ...
Here's How Many Shares Of AbbVie You Would Need To Earn $500 Per Month In Dividends
Benzinga via Yahoo Finance· 14 hours agoWith 52 consecutive years of dividend growth and a dividend yield of over 3.6%, AbbVie Inc....
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 2 days agoBecause of this, empirical studies indicate a strong correlation between trends in earnings estimate...
State Farm Mutual Automobile Insurance Co. Has $961.26 Million Stock Holdings in AbbVie Inc....
ETF DAILY NEWS· 2 days agoState Farm Mutual Automobile Insurance Co. decreased its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 1.8% during the 4th quarter, according to ...
The Art of Valuation: Discovering AbbVie Inc's Intrinsic Value
GuruFocus.com via Yahoo Finance· 3 days agoAs of 2024-06-11, AbbVie Inc's intrinsic value as calculated by the Discounted Earnings model is...
AbbVie, Amazon, Goldman Sachs And 2 Major Health Care Stocks On CNBC's 'Final Trades' - AbbVie...
Benzinga· 7 days agoAbbVie Inc. has good dividend yield and attractive valuations, according to Jim Lebenthal of Cerity...
AbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal
Zacks via Yahoo Finance· 7 days agoData from a mid-stage study shows that treatment with AbbVie's (ABBV) Elahere achieves an objective...
Goldman Sachs Optimistic About Regenxbio's Gene Therapy Pipeline, Sees Over 160% Upside - Regenxbio...
Benzinga· 6 days agoGoldman Sachs initiates coverage on RGNX, citing potential of gene therapy platform.
These Biotech Stocks Hit New Highs, Did You Reap The Rewards?
RTT News· 7 days agoThe following compilation represents a selection of stocks featured on our website that reached new 52-week high levels during the current week. Protagonist is a clinical-stage biopharmaceutical ...
REGENXBIO appoints new CEO, maintains financial outlook By Investing.com
Investing.com· 2 days agoBiotechnology firm REGENXBIO Inc. (NASDAQ:RGNX) on Wednesday announced a leadership transition, with...